Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

TADAWUL:2070 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	203.91	122.14	160.07	335.35	328.32
Short-Term Investments	179.98	155	115.5	45	-
Trading Asset Securities	0.5	0.48	0.46	0.42	567.67
Cash & Short-Term Investments	384.38	277.62	276.03	380.77	895.99
Cash Growth	38.45%	0.58%	-27.51%	-57.50%	-16.62%
Accounts Receivable	1,176	1,175	881.83	758.9	971.8
Other Receivables	83.11	64.87	35.42	147.12	94.29
Receivables	1,260	1,240	917.26	906.03	1,066
Inventory	611.03	646.09	589.21	494.69	419.09
Prepaid Expenses	21.4	18.56	22.98	23.73	23.99
Other Current Assets	99.78	174.13	103.17	70.56	57.16
Total Current Assets	2,376	2,356	1,909	1,876	2,462
Property, Plant & Equipment	1,753	1,748	1,825	1,829	1,818
Long-Term Investments	81.43	67.73	58.19	46.53	63.3
Other Intangible Assets	134.81	125.61	60.64	50.33	69.54
Long-Term Deferred Tax Assets	22.25	21.4	28.6	23.48	18.93
Long-Term Deferred Charges	-	-	-	6.67	1.9
Total Assets	4,368	4,319	3,881	3,832	4,434
Accounts Payable	373.73	446.3	318.98	223.01	303.65
Accrued Expenses	265.24	255.4	253.54	87.14	125.91
Short-Term Debt	625.23	-	2.05	197.32	170.15
Current Portion of Long-Term Debt	340.2	1,039	523.41	479.64	682.6
Current Portion of Leases	1.75	3.04	7.21	6.15	7.26
Current Income Taxes Payable	52.09	62.44	48.45	33.14	28.84
Other Current Liabilities	201.62	204.24	257.21	322.44	321.34
Total Current Liabilities	1,860	2,010	1,411	1,349	1,640
Long-Term Debt	462.18	462.46	575.28	379.83	417.12
Long-Term Leases	4.94	8.37	11.3	18.81	17.69
Long-Term Unearned Revenue	91.54	84.81	85.03	77.95	70.23
Pension & Post-Retirement Benefits	187.09	222.3	282.71	313.24	295.89
Total Liabilities	2,606	2,788	2,365	2,139	2,441
Common Stock	1,200	1,200	1,200	1,200	1,200
Retained Earnings	440.16	240.41	225.21	366.29	649.68
Treasury Stock	-19.94	-19.94	-8	-	-
Comprehensive Income & Other	-23.58	-42.17	-42.03	-26.79	-11.91
Total Common Equity	1,597	1,378	1,375	1,540	1,838
Minority Interest	165.51	153.02	140.42	153.6	155.64
Shareholders' Equity	1,762	1,531	1,516	1,693	1,993
Total Liabilities & Equity	4,368	4,319	3,881	3,832	4,434
Total Debt	1,434	1,513	1,119	1,082	1,295
Net Cash (Debt)	-1,050	-1,235	-843.22	-700.97	-398.82
Net Cash Per Share	-8.80	-10.33	-7.05	-5.84	-3.32
Filing Date Shares Outstanding	119.36	120	120	120	120
Total Common Shares Outstanding	119.36	120	120	120	120
Working Capital	516.28	346.18	497.79	526.94	822.58
Book Value Per Share	13.38	11.49	11.46	12.83	15.31
Tangible Book Value	1,462	1,253	1,315	1,489	1,768
Tangible Book Value Per Share	12.25	10.44	10.95	12.41	14.74
Land	107.55	115.87	120.93	122.04	122.05
Buildings	1,212	1,206	1,009	772.75	776.76
Machinery	1,350	1,319	1,196	1,106	1,107
Construction In Progress	202.91	149.01	483.48	753.81	686.46

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.